Announcements Trials
Browse Landscape

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 24Other hematologic neoplasm 3Lymphoid 3Genitourinary 3Gastrointestinal 3Sarcoma 2Plasma cell 2Other 2Breast 2Myeloid 1Head & Neck 1Gynecologic 1Classical hematology 1CNS 1

Conditions

Multiple Myeloma 7Neoplasms, Plasma Cell 2Neoplasms 2Lymphoma 2Colorectal Neoplasms 2Breast Neoplasms 2Thyroid Neoplasms 1Thyroid Diseases 1Prostatic Neoplasms 1Pain 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Dexamethasone 33Lenalidomide 14pomalidomide 12daratumumab 12Bortezomib 12venetoclax 7Cyclophosphamide 7isatuximab 6Therapeutics 6trametinib 4carfilzomib 4Trimethoprim, Sulfamethoxazole Drug Combination 4gamma-Globulins 3fludarabine 3dabrafenib 3Vemurafenib 3Rituximab 3Peripheral Blood Stem Cell Transplantation 3Melphalan 3Drug Therapy 3Denosumab 3Ciprofloxacin 3Calcium Dobesilate 3ridaforolimus 2pembrolizumab 2molibresib 2liposomal amphotericin B 2fludarabine phosphate 2cobimetinib 2afuresertib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Interviews as Topic × Plasma cell × Clear all
NCT06236373 2024-12-09

Survivorship

University of Modena and Reggio Emilia

Recruiting
45 enrolled
BreastGastrointestinalGenitourinaryHead & NeckLymphoidPlasma cell

Breast Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Prostatic Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Colorectal Neoplasms, Neoplasms, Plasma Cell

NCT01016028 2016-05-03

Chemotherapy-Induced Peripheral Neuropathy Survey

M.D. Anderson Cancer Center

Withdrawn
BreastGastrointestinalPlasma cell

Breast Neoplasms, Neoplasms, Pain, Colorectal Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡